To access this element change to forms mode OFF
Grant Award View - GA207600
Pioneering novel therapeutic strategies to enhance an anti-tumour immune...
GA ID:
GA207600
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$721,983.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Pioneering novel therapeutic strategies to enhance an anti-tumour immune response in Neuroblastoma
Purpose:
Neuroblastoma has one of the lowest survival rates of all childhood cancers. Immunotherapy stimulates an immune response against cancer cells yet still works poorly in neuroblastoma. This suggests that understanding how neuroblastoma evade immune system is critical to improving such therapies. Our research has found that copper plays a key role in tumours to evade the immune response. We are currently developing new strategies to reduce copper and activate the anti-tumour immune responses.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012567
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, VIC
Postcode:
Multiple
Country:
AUSTRALIA